Citi Pharma Limited (PSX:CPHL)

Citi Pharma Revenue

In the fiscal year ending June 30, 2026, Citi Pharma had annual revenue of 14.08B PKR with 7.01% growth. Citi Pharma had revenue of 3.29B in the quarter ending June 30, 2026, with 7.69% growth. That makes Citi Pharma the 27,846th largest company in the world by revenue and 183rd in Pakistan.

• Revenue: 14.08B
• Revenue Growth: +7.01%
• P/S Ratio: 1.01
• Revenue / Employee: 25.69M
• Employees: 548
• Market Cap: 14.17B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	14.08B	922.28M	7.01%
Jun 30, 2025	13.15B	744.28M	6.00%
Jun 30, 2024	12.41B	12.26M	0.10%
Jun 30, 2023	12.40B	2.62B	26.76%
Jun 30, 2022	9.78B	3.98B	68.75%

Data Source: S&P Global Market Intelligence Last updated: Oct 7, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 16, 2026

Data Sources Report a data error